or
forgot password

    • cancer clinical trials in rancho mirage, CA

    • Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma
    Cancer and Blood Institute of the Desert
    Rancho Mirage, California 92270
    Melanoma (Skin)
    Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
    Cancer and Blood Institute of the Desert
    Rancho Mirage, California 92270
    Lymphoma
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    Cancer and Blood Institute of the Desert
    Rancho Mirage, California 92270
    Colorectal Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Lucy Curci Cancer Center at Eisenhower Memorial Hospital and Medical Center
    Rancho Mirage, California 92270
    Lung Cancer
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    Cancer and Blood Institute of the Desert
    Rancho Mirage, California 92270
    Colorectal Cancer
    Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
    Cancer and Blood Institute of the Desert
    Rancho Mirage, California 92270
    Leukemia, Lymphoma
    PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
    Desert Hematology Oncology Medical Group, Inc
    Rancho Mirage, California 92270
    Pancreatic Cancer
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    Cancer and Blood Institute Medical Group
    Rancho Mirage, California 92270
    Chronic Lymphocytic Leukemia
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Lucy Curci Cancer Center at Eisenhower Memorial Hospital and Medical Center
    Rancho Mirage, California 92270
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Eisenhower Medical Center
    Rancho Mirage, California 92270
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    Lucy Curci Cancer Center at Eisenhower Memorial Hospital and Medical Center
    Rancho Mirage, California 92270
    Prostate Cancer
    Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
    Access Clinical Research

    Trial Locations
    Access Clinical Research
    Cancer and Blood of the Desert
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Lucy Curci Cancer Center at Eisenhower Memorial Hospital and Medical Center
    Rancho Mirage, California 92270
    Breast Cancer
    Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer
    Desert Hematology Oncology Medical Group, Inc
    Rancho Mirage, California 92270
    Non-small Cell Lung Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Eisenhower Medical Center
    Rancho Mirage, California 92270
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
    Desert Hematology-Oncology Medical Group, Incorporated
    Rancho Mirage, California 92270
    Breast Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Eisenhower Medical Center
    Rancho Mirage, California 92270
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
    Desert Cancer Care
    Rancho Mirage, California 92270
    Multiple Myeloma and Plasma Cell Neoplasm
    Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer
    Desert Hematology Oncology Medical Group
    Rancho Mirage, California 92270
    Prostatic Neoplasms
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    Desert Hematology Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Metastatic Pancreatic Cancer
    Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
    Desert Hematology Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Relapsed or Refractory Chronic Lymphocytic Leukemia
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Lucy Curci Cancer Center at Eisenhower Memorial Hospital and Medical Center
    Rancho Mirage, California 92270
    Colorectal Cancer, Precancerous Condition
    Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
    Desert Hematology Oncology
    Rancho Mirage, California 92270
    Prostate Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Lucy Curci Cancer Center at Eisenhower Memorial Hospital and Medical Center
    Rancho Mirage, California 92270
    Kidney Cancer
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Eisenhower Medical Center
    Rancho Mirage, California 92270
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Eisenhower Medical Center
    Rancho Mirage, California 92270
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Eisenhower Medical Center
    Rancho Mirage, California 92270
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
    Hope Square Surgical Center
    Rancho Mirage, California 92270
    Ulcerative Colitis
    A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
    Desert Hematology Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Colorectal Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Desert Hematology Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Colorectal Cancer
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Desert Hematology Oncology Medical Group
    Rancho Mirage, California 92270
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia
    Eisenhower Med Ctr
    Rancho Mirage, California 92270
    Anorexia, Cachexia, HIV Infections
    A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition
    Eisenhower Med Ctr
    Rancho Mirage, California 92270
    Anorexia, Cachexia, HIV Infections
    Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
    Eisenhower Medical Center
    Rancho Mirage, California 92270
    Chronic Myeloproliferative Disorders, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
    Lucy Curci Cancer Center at Eisenhower Memorial Hospital and Medical Center
    Rancho Mirage, California 92270
    Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer
    Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
    Cancer and Blood Institute of the Desert
    Rancho Mirage, California 92270
    Hypercalcemia of Malignancy, Lung Cancer, Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    Eisenhower Medical Center

    Trial Locations
    Eisenhower Medical Center
    Cancer and Blood Institute of the Desert
    Prostate Cancer
    A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
    Desert Hematology Oncology Medical Group INC
    Rancho Mirage, California 92270
    Myelodysplastic Syndromes
    Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
    Desert Hematology-Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Non-small Cell Lung Cancer
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    The Lucy Curci Cancer Center
    Rancho Mirage, California 92270
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
    Desert Hematology Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Myelodysplastic Syndromes
    Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
    Desert Hematology & Oncology Medical Group
    Rancho Mirage, California 92270
    Myelodysplastic Syndromes
    Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma
    Cancer and Blood Institute Medical Group
    Rancho Mirage, California 92270
    Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Cancer and Blood Institute Medical Group
    Rancho Mirage, California 92270
    Lung Cancer, Non-small-cell Lung Carcinoma
    ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer
    Desert Hematology Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Pancreatic Cancer, Adenocarcinoma
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Desert Hematology Oncology Medical Group
    Rancho Mirage, California 92270
    Multiple Myeloma
    Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
    Desert Hematology Oncology Medical Group
    Rancho Mirage, California 92270
    Prostate Cancer
    Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer
    Desert Hematology Oncology Medical Group
    Rancho Mirage, California 92270
    Breast Neoplasm
    Ph 3 Randomized Study of Telcyta® + Liposomal Doxorubicin Vs Liposomal Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer
    Desert Hematology Oncology Medical Group
    Rancho Mirage, California 92270
    Ovarian Neoplasms
    A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
    Site Ref # / Investigator 3567
    Rancho Mirage, California 92270
    Lung Cancer, Non-Small Cell Lung Cancer
    GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
    Desert Hematology Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Advanced Unresectable Pancreatic Cancer
    Efficacy of SNX-1012 in the Treatment of Oral Mucositis
    Desert Hematology Oncology Medical Group
    Rancho Mirage, California 92270
    Stomatitis, Oral Mucositis
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Desert Cardiology Consultants Medical Group, Inc
    Rancho Mirage, California 92270
    Atrial Fibrillation, Atrial Flutter
    A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma
    Access Clinical Research
    Rancho Mirage, California 92270
    Lymphoma, Non-Hodgkin's
    A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
    Desert Hematology Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic
    Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
    Desert Hematology Oncology Medical Group
    Rancho Mirage, California 92270
    Cachexia
    Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia
    Desert Hematology Oncology Medical Group
    Rancho Mirage, California 92270
    Breast Cancer, Neutropenia
    A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer
    Desert Hematology Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Pancreatic Cancer
    A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
    Desert Hematology Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Non Small Cell Lung Cancer
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    Desert Hematology Oncology Medical Group
    Rancho Mirage, California 92270
    Myelodysplastic Syndrome (MDS)
    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
    Desert Hematology Medical Group, Inc.
    Rancho Mirage, California 92270
    Relapsed Follicular Lymphoma
    Trial of Romidepsin and Bortezomib for Multiple Myeloma
    Desert Cancer Care, Inc
    Rancho Mirage, California 92270
    Multiple Myeloma
    Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
    Desert Hematology Oncology Medical Group
    Rancho Mirage, California 92270
    Tumor, Breast Cancer
    First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
    Desert Hematology Oncology Medical Group, Inc.
    Rancho Mirage, California 92270
    Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion, Stage IV Non-small Cell Lung Cancer